Navigation Links
Discovered a new checkpoint of cell cycle control through joint action of 2 proteins
Date:5/22/2012

Alterations in the formation of ribosomes (the elements of the cell where proteins are made) cause the induction of p53 protein and cell cycle disruption. This process is crucial to understand fundamental biological processes and the emergence of various diseases. Now, scientists at the Bellvitge Biomedical Research Institute (IDIBELL) have found that this response is achieved independently, depending on which subunit of the ribosome (40S and 60S) is impaired, by the joint action of two proteins of the ribosome. The research results are published in the latest issue of the journal Genes and Development.

The p53 protein, produced by the gene of the same name, is a tumour suppressor in humans and other mammals. Half of human tumours have mutations in the p53 gene and alterations of regulators of this gene are present in many other cancers. However, p53 is not only a tumour suppressor but is involved in other cellular processes such as longevity, mitochondrial oxidation and glucose metabolism. Activation of p53 protein due to malfunctions in the formation of ribosomes is associated with several rare diseases that are linked with mutations in components of the cell nucleus.

The study by IDIBELL researchers shows that ribosomal proteins RPL11 and RPL5 cooperate to suppress Hdm2, another protein that regulates the degradation of p53. This causes increased levels of p53 and cell cycle arrest. These results are contrary to previous dogma, claiming that other ribosome proteins could elicit a similar response to RPL11 and RPL5.

The coordinator of the study, George Thomas, director of the research group of Metabolic Diseases and Cancer at IDIBELL explains that the knowledge of this mechanism "may have implications in understanding fundamental processes such as longevity, metabolic diseases or cancer and can provide a basis for developing new drugs."


'/>"/>
Contact: Jordi Morat
comunicacio@idibell.cat
IDIBELL-Bellvitge Biomedical Research Institute
Source:Eurekalert

Page: 1

Related biology news :

1. New key mechanism in cell division discovered
2. Low-cost nanosheet catalyst discovered to split hydrogen from water
3. Global warming refuge discovered near at-risk Pacific island nation of Kiribati
4. Key proteins newly discovered form and function may provide novel cancer treatment target
5. 24 new species of lizards discovered on Caribbean islands are close to extinction
6. New form of intellectual disability discovered
7. Scientists have discovered genes that increase the risk of osteoporosis and fractures
8. Housekeeping mechanism for brain stem cells discovered
9. New genetic mechanism of immune deficiency discovered
10. New immune defense enzyme discovered
11. Newly discovered foot points to a new kid on the hominin block
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to inform its ... of Washington,s Department of Licensing, in the United ... system for driver,s licenses and identification cards to its subsidiary, ... will start in January 2015, with enrollment and card production ...
(Date:1/22/2015)... 16, 2015  A man-made form of insulin delivered by ... capabilities in adults with mild cognitive impairment and Alzheimer,s ... researchers at Wake Forest Baptist Medical Center. ... mild cognitive impairment (MCI) or mild to moderate Alzheimer,s ...
(Date:1/22/2015)... and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ) has ... Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, ... report to their offering. , ... be worn on the user,s body and have ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2
... of green foliage around the globe, observed since the ... part from the increasing concentration of carbon dioxide in ... the globe finds that a carbon dioxide "fertilization effect" ... 2010. Focusing on the southwestern corner of North ...
... countries have joined the International Osteoporosis Foundation (IOF) and ... Conference of Osteoporosis Patient Societies. The conference is ... Paasitorni. Osteoporosis, known as the ,silent, ... easily prone to fracture even after a minor bump ...
... that a simple program that uses pedometers to monitor how ... physical activity, decreasing sitting time, a particular problem for office ... if somebody works out 30 minutes a day, the fact ... time for the rest of the day is in and ...
Cached Biology News:Elevated carbon dioxide making arid regions greener 2Elevated carbon dioxide making arid regions greener 3IOF Worldwide Conference of Osteoporosis Patient Societies opens in Helsinki 2Study: Pedometer program helps motivate participants to sit less, move more 2
(Date:1/23/2015)... stimulate microbial activities in soil. These microorganisms generate plant ... in the soil or in the rhizosphere. The demand ... reducing environmental pollution and on reducing the usage of ... bio fertilizers market with analysis and forecasting of the ...
(Date:1/22/2015)... January 22, 2015 Shimadzu Scientific ... UV-1280 multipurpose UV-visible spectrophotometer. Offering wavelength scanning from ... is ideal for applications in a variety of ... , The user-friendly UV-1280 enables intuitive operation, while ...
(Date:1/22/2015)... Mass (PRWEB) January 21, 2015 Cambridge Semantics, ... Web technology, today announced that 2014 was a record-breaking year ... the capabilities of the Anzo Smart Data Platform and our ... and utilize insights from diverse data which led to record ...
(Date:1/22/2015)... Pipette.com has added the Eppendorf ... portfolio of Eppendorf products. , The Eppendorf Centrifuge 5424/5424 ... 5424/5424 R and receive the following:, , ... or Eppendorf Reference 2 ,     3 Free ...
Breaking Biology Technology:Biofertilizers Market Expected to Reach $1,649.7 Million by 2019 - New Report By MarketsandMarkets 2Biofertilizers Market Expected to Reach $1,649.7 Million by 2019 - New Report By MarketsandMarkets 3Biofertilizers Market Expected to Reach $1,649.7 Million by 2019 - New Report By MarketsandMarkets 4Shimadzu’s New Monitored Single-Beam UV-Vis Spectrophotometer Offers Comprehensive Measurement Options in a Compact Body 2Cambridge Semantics Announces Record Results for 2014 2Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2
... to Battelle for submission of proposals to U.S. ... Corgenix Medical Corporation (OTC Bulletin Board: CONX), a ... has announced a collaboration with Battelle, a Columbus, ... focus includes national security. Under the collaboration, Corgenix ...
... in Treatment of Skin InfectionsNEW HAVEN, Conn., Jan. ... "Company"), a development-stage company focused on the discovery ... of antibiotic-resistant infections, today announced positive final results ... novel fluoroquinolone antibiotic, delafloxacin (RX-3341), in the treatment ...
... Neuralstem, Inc. (NYSE Alternext US: CUR) today announced ... for its patent application, number 10/047,352, for Stable ... and Trade Office (USPTO). This patent covers the ... rendering its growth robust and long-lasting. , (Logo: ...
Cached Biology Technology:Corgenix Signs Collaboration With Battelle 2Corgenix Signs Collaboration With Battelle 3Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing 2Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing 3Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing 4Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing 5Neuralstem Receives Final Notice of Allowance for New Stem Cell Immortalization Technology Patent 2Neuralstem Receives Final Notice of Allowance for New Stem Cell Immortalization Technology Patent 3
... Fixed clamp trays and ... Magnetic drive ... 25 mm amplitude ... ml to 2000 ml, including Fernbach ...
... The MONOLIGHT 3096 Microplate Luminometer ... chemi- and bioluminescence and for,all measurements ... microplates,i.e. for reactions where the light ... of time, as well as for ...
... This kit allows for rapid, convenient, ... The simple bind/wash/elute process utilizes a spin ... uses beads for concentration of proteins which ... beads are strong ion exchangers, offering high ...
... results sooner and save hours of valuable research ... need for a membrane transfer step and western ... No reagents to prepare or mix or dilute ... a simple to perform, mistake-free detection protocol. ...
Biology Products: